Professor of Medicine, Professor of Pediatrics, Professor of Cellular and Molecular Physiology, Direction of Metabolic Liver Disease and Lysosomal Disease Center, Yale School of Medicine
Gastroenterology
Dr. Pramod K. Mistry, MD
|
|
Give Review
Pramod Mistry works in the field of Gastroenterology. Pramod K. Mistry is a published MD. He published 76 publications, including: 'Ulcerative colitis has an aggressive course after orthotopic liver transplantation for primary sclerosing cholangitis.'
Publications
- Recommendations for the use of eliglustat in the treatment of adults with Gaucher disease type 1 in the United States.
- Effect of oral eliglustat on splenomegaly in patients with Gaucher disease type 1: the ENGAGE randomized clinical trial.
- Type II NKT-TFH cells against Gaucher lipids regulate B cell immunity and inflammation.
- Individual exome analysis in diagnosis and management of paediatric liver failure of indeterminate aetiology.
- Glucocerebrosidase 2 gene deletion rescues type 1 Gaucher disease.
- Treatment for LSDs: no longer just enzyme replacement therapy for Gaucher disease. Foreword.
- Gaucher disease and malignancy: a model for cancer pathogenesis in an inborn error of metabolism.
- Calcium Ameliorates Diarrhea In Immune Compromised Children.
- Disease state awareness in Gaucher disease: a q&a expert roundtable discussion.
- Genome-wide association study of N370S homozygous Gaucher disease reveals the candidacy of CLN8 gene as a genetic modifier contributing to extreme phenotypic variation.
- Elevated plasma glucosylsphingosine in Gaucher disease: relation to phenotype, storage cell markers, and therapeutic response.
- Recombinant macrophage targeted enzyme replacement therapy for Gaucher disease in India.
- Reducing selection bias in case-control studies from rare disease registries.
- Pulmonary vascular disease in Gaucher disease: clinical spectrum, determinants of phenotype and long-term outcomes of therapy.
- Evaluation of high density lipoprotein as a circulating biomarker of Gaucher disease activity.
- Osteopenia in Gaucher disease develops early in life: response to imiglucerase enzyme therapy in children, adolescents and adults.
- A reappraisal of Gaucher disease-diagnosis and disease management algorithms.
- Focal splenic lesions in type I Gaucher disease are associated with poor platelet and splenic response to macrophage-targeted enzyme replacement therapy.
- Glucocerebrosidase gene-deficient mouse recapitulates Gaucher disease displaying cellular and molecular dysregulation beyond the macrophage.
- Long-term outcomes of liver transplantation in type 1 Gaucher disease.
- Hyperferritinemia and iron overload in type 1 Gaucher disease.
- High incidence of cholesterol gallstone disease in type 1 Gaucher disease: characterizing the biliary phenotype of type 1 Gaucher disease.
- Expanding spectrum of the association between Type 1 Gaucher disease and cancers: a series of patients with up to 3 sequential cancers of multiple types--correlation w...
- The risk of Parkinson''s disease in type 1 Gaucher disease.
- Abnormal nonstoring capillary endothelium: a novel feature of Gaucher disease. Ultrastructural study of dermal capillaries.
- Protease activation during in vivo pancreatitis is dependent on calcineurin activation.
- Timing of initiation of enzyme replacement therapy after diagnosis of type 1 Gaucher disease: effect on incidence of avascular necrosis.
- Gaucher disease: resetting the clinical and scientific agenda.
- The underrecognized progressive nature of N370S Gaucher disease and assessment of cancer risk in 403 patients.
- Dose-response relationships for enzyme replacement therapy with imiglucerase/alglucerase in patients with Gaucher disease type 1.
- Life expectancy in Gaucher disease type 1.
- Correlation of MRI-Based bone marrow burden score with genotype and spleen status in Gaucher's disease.
- Management of non-neuronopathic Gaucher disease with special reference to pregnancy, splenectomy, bisphosphonate therapy, use of biomarkers and bone disease monitoring.
- Inherited metabolic disease of the liver.
- Microvillus inclusion disease associated with coarctation of the aorta and bicuspid aortic valve.
- Increased T-cell sinusoidal lymphocytosis in liver biopsies in patients with chronic hepatitis C and mixed cryoglobulinemia.
- Prevalence of type 1 Gaucher disease in the United States.
- Therapeutic objectives in Gaucher disease.
- Consequences of diagnostic delays in type 1 Gaucher disease: the need for greater awareness among hematologists-oncologists and an opportunity for early diagnosis and ...
- Phenotype variations in Gaucher disease.
- Therapeutic goals in Gaucher disease.
- Enzyme replacement therapy and bony changes in Egyptian paediatric Gaucher disease patients.
- Guidance on the use of miglustat for treating patients with type 1 Gaucher disease.
- Hepatocellular carcinoma in type 1 Gaucher disease: a case report with review of the literature.
- Individualization of long-term enzyme replacement therapy for Gaucher disease.
- Phase I and pharmacokinetic study of XR11576, an oral topoisomerase I and II inhibitor, administered on days 1-5 of a 3-weekly cycle in patients with advanced solid tu...
- Gaucher disease type 1: revised recommendations on evaluations and monitoring for adult patients.
- Therapeutic goals in the treatment of Gaucher disease.
- Enzyme replacement therapy and monitoring for children with type 1 Gaucher disease: consensus recommendations.
- Pulmonary hypertension in type 1 Gaucher's disease: genetic and epigenetic determinants of phenotype and response to therapy.
- Effectiveness of enzyme replacement therapy in 1028 patients with type 1 Gaucher disease after 2 to 5 years of treatment: a report from the Gaucher Registry.
- Failure of resting echocardiography and cardiac catheterization to identify pulmonary hypertension in two patients with type I Gaucher disease.
- Metabolic liver disease.
- Molecular diagnosis of Wilson disease.
- In vitro and in vivo reversal of P-glycoprotein-mediated multidrug resistance by a novel potent modulator, XR9576.
- The Gaucher registry: demographics and disease characteristics of 1698 patients with Gaucher disease.
- Treatment of Gaucher''s disease with OGT 918.
- Oxidative-phosphorylation defects in liver of patients with Wilson''s disease.
- Gaucher disease: the origins of the Ashkenazi Jewish N370S and 84GG acid beta-glucosidase mutations.
- Gaucher''s disease: a model for modern management of a genetic disease.
- Ulcerative colitis has an aggressive course after orthotopic liver transplantation for primary sclerosing cholangitis.
- Combined liver-kidney transplantation in methylmalonic acidemia.
- Outcome of orthotopic liver transplantation in patients with haemophilia.
- A practical approach to diagnosis and management of Gaucher''s disease.
- Therapeutic delivery of proteins to macrophages: implications for treatment of Gaucher''s disease.
- The association between free fatty acid concentrations and triglyceride-rich lipoproteins in the post-prandial state is altered by a common deletion polymorphism of th...
- Genotype/phenotype correlations in Gaucher''s disease.
- High expression of osteopontin mRNA in human macrophages but not human vascular smooth muscle cells in culture.
- The glucocerebrosidase locus in Gaucher''s disease: molecular analysis of a lysosomal enzyme.
- Successful treatment of bone marrow failure in Gaucher''s disease with low-dose modified glucocerebrosidase.
- Genetic diagnosis of Gaucher''s disease.
- Inhibition of platelet aggregation by abnormal high density lipoprotein particles in plasma from patients with hepatic cirrhosis.
- Abnormal high density lipoproteins from patients with liver disease regulate cholesterol metabolism in cultured human skin fibroblasts.
- Individual variation in the effects of dietary cholesterol on plasma lipoproteins and cellular cholesterol homeostasis in man. Studies of low density lipoprotein recep...
- Splanchnic production of discoidal plasma high-density lipoprotein in man.
Schools
Royal Free Hospital School Of Medicine University Of London
Doctors Specialties
- Internal Medicine
- Gastroenterology
Accepted Insurances
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1588648851 |
| Last Name Of The Provider | MISTRY |
| First Name Of The Provider | PRAMOD |
| View All |
Similar Doctors
|
|
Dr. Peggy H. Harris, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Salomeh Keyhani, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Aparna Goel, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Jason S. Yip, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Alexandra M. Dow, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jeremy L. Matloff, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Sang Kim, MD |
|
|
Dr. Dennis B. Liotta, MD |
|
|
Dr. Milan M. Patel, MD |
|
|
Dr. Mari Ikeguchi, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Sukanya Subramanian, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Christian D. Espana Schmidt
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Paul R. Haller, MD
This Doctor is OpenDoctor Recommended.
|